The concept of organisational cost reduction has been at the top of corporate agendas ever since the global financial crisis of 2008-2009. In the immediate aftermath of the global recession, organisational cost reduction emerged as not only a necessity, but also a field that provided ample scope for innovation. For a long time, the question…
With a recent cost survey by Deloitte showing that 88 percent of companies will be pursuing cost-reduction measures over the next 24 months, effective cost strategies have never been in greater demand. As part of Naseba’s ongoing effort to meet this demand, we’ve researched and summarised 10 key strategies to help your organisation cut costs…
Earlier this year, the pharmaceutical arm of Fosun International, a Chinese company with a market cap of over 13 billion USD, announced a1.3 billion USD buyout of India based Gland Pharma. Chinese companies are increasingly making healthcare deals abroad in order to become relevant and active players in the global healthcare market. The domestic market…
I-Bridge Capital, a health-care focused venture capital firm and incubator based in Shanghai, has announced the establishment of a joint venture with BioLineRx Ltd., a drug company based in Israel. The venture will incubate healthcare startups, in order to develop innovative clinical and pre-clinical therapeutic projects. Though these projects will originate primarily in Israel, they…